BMP2: A Potential Drug Target for Cancer and Neurodegenerative Diseases

Target Name: BMP2

NCBI ID: G650

BMP2: A Potential Drug Target for Cancer and Neurodegenerative Diseases

Bone Morphogenetic Protein 2A (BMP2) is a transmembrane protein that plays a crucial role in cell proliferation, differentiation, and tissue engineering. It is a potent regulator of several cellular processes, including cell adhesion, migration, and angiogenesis. BMP2 has also been implicated in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, it has become an attractive drug target for researchers to explore new treatments for these diseases.

BMP2 was first identified in 1995 as a cell surface protein that was able to induce a variety of cellular processes, including cell adhesion, migration, and investment in human cells. It is a member of the TGF-β family, which includes several other proteins that are involved in cell signaling pathways, including TGF-β1, TGF-β2, and TGF-β3. TGF-β signaling is a complex process that involves the regulation of cellular processes such as cell adhesion, migration, and angiogenesis.

One of the key functions of BMP2 is its ability to induce cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. BMP2 plays a crucial role in this process by promoting the formation of tight junctions between cells, which are responsible for maintaining the integrity of tissues. tight junctions are also important for the regulation of ion and solute transport, as well as the maintenance of electrical stability within cells.

BMP2 has also been shown to promote cell migration. During the development of tissues and organs, cells must move from one location to another in order to create new tissues and organs. BMP2 plays a crucial role in this process by promoting the production of a protein called run-on-cone, which is involved in cell migration. Run-on-cone is a protein that is able to interact with several different cellular signaling pathways, including the TGF-β pathway. This interaction between BMP2 and run-on- cone allows for the regulation of cell migration and the formation of new tissues and organs.

In addition to its role in cell adhesion and migration, BMP2 has also been shown to be involved in the regulation of several other cellular processes. For example, it has been shown to play a role in the regulation of cell proliferation, and it has been shown to interact with several different proteins that are involved in cell signaling, including TGF-β2, PDGFR-尾, and NF-kappa-B. Additionally, BMP2 has been shown to be involved in the regulation of several cellular processes that are important for tissue engineering , including the regulation of cell extramatrix (cell extramatrix) production, angiogenesis, and the regulation of cellular communications.

Due to its involvement in so many cellular processes, BMP2 has become an attractive drug target for several diseases. For example, BMP2 has been shown to be involved in the regulation of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In cancer, BMP2 has been shown to play a role in the regulation of cell proliferation, and it has been shown to interact with several different proteins that are involved in cell signaling, including TGF-β2, PDGFR-尾, and NF-kappa-B. Additionally, studies have shown that BMP2 can inhibit the activity of several different chemotherapy drugs, including taxanes and vinca alkaloids. This suggests that BMP2 may be an effective target for cancer therapies that involve inhibition of cell proliferation.

In neurodegenerative diseases, BMP2 has been shown to play a role in the regulation of cell proliferation and survival. Additionally, studies have shown that BMP2 can interact with several different proteins that are involved in

Protein Name: Bone Morphogenetic Protein 2

Functions: Growth factor of the TGF-beta superfamily that plays essential roles in many developmental processes, including cardiogenesis, neurogenesis, and osteogenesis (PubMed:18436533, PubMed:31019025, PubMed:24362451). Induces cartilage and bone formation (PubMed:3201241). Initiates the canonical BMP signaling cascade by associating with type I receptor BMPR1A and type II receptor BMPR2 (PubMed:15064755, PubMed:17295905, PubMed:18436533). Once all three components are bound together in a complex at the cell surface, BMPR2 phosphorylates and activates BMPR1A (PubMed:7791754). In turn, BMPR1A propagates signal by phosphorylating SMAD1/5/8 that travel to the nucleus and act as activators and repressors of transcription of target genes. Can also signal through non-canonical pathways such as ERK/MAP kinase signaling cascade that regulates osteoblast differentiation (PubMed:20851880, PubMed:16771708). Stimulates also the differentiation of myoblasts into osteoblasts via the EIF2AK3-EIF2A-ATF4 pathway by stimulating EIF2A phosphorylation which leads to increased expression of ATF4 which plays a central role in osteoblast differentiation (PubMed:24362451)

More Common Targets